Insmed expects to grant the underwriters a 30-day option to purchase up to an aggregate of 1.5 million additional shares of common stock at the offering price. The offering is subject to market and other conditions, and there can be no assurance as to whether or when the offering may be completed, or as to the actual size or terms of the offering. All of the shares in the offering will be sold by Insmed. Insmed Incorporated announced today that it is offering $60 million of its common stock in a proposed underwritten public offering. Insmed Announces Proposed Public Offering of Common Stock MONMOUTH JUNCTION, NJ -- (Marketwired) -- 07/15/13 -- Insmed Incorporated (NASDAQ: INSM) ("Insmed") announced today that it is offering $60 million of its common stock in a proposed underwritten public offering. All of the shares in the offering will be sold by Insmed. BRIDGEWATER, N.J., May 20, 2019 /PRNewswire/ -- Insmed Incorporated (Nasdaq: INSM) announced today that it has commenced an underwritten public offering of up to $250 million of its common stock. In addition, Insmed intends to grant the underwriters a 30-day option to purchase up
The underwriters were granted 30-day options to purchase up to an additional 1,042,307 shares of common stock from Insmed and up to 400,000 shares of common stock from William H. Lewis, the Insmed issued and sold in the public offering 9,615,385 shares of common stock, at a public offering price of $26.00 per share, resulting in gross proceeds of approximately $250.0 million. BRIDGEWATER, N.J., May 21, 2019 /PRNewswire/ -- Insmed Incorporated (Nasdaq: INSM) announced today that it priced a registered underwritten public offering of 9,615,385 shares of its common stock, at a price to the public of $26.00 per share before underwriting discounts and commissions.
BRIDGEWATER, N.J., May 20, 2019 /PRNewswire/ -- Insmed Incorporated (Nasdaq: INSM) announced today that it has commenced an underwritten public offering of up to $250 million of its common stock. In addition, Insmed intends to grant the underwriters a 30-day option to purchase up to an additional $25.5 million of its common stock at the public offering price, less the underwriting discounts and commissions. BRIDGEWATER, N.J., May 20, 2019 /PRNewswire/ -- Insmed Incorporated (INSM) announced today that it has commenced an underwritten public offering of up to $250 million of its common stock. In
BRIDGEWATER, N.J., May 21, 2019 /PRNewswire/ -- Insmed Incorporated (Nasdaq: INSM) announced today that it priced a registered underwritten public offering of 9,615,385 shares of its common stock, at a price to the public of $26.00 per share before underwriting discounts and commissions. Insmed Announces Proposed Public Offering of Common Stock - May 20, 2019 - read this article along with other careers information, tips and advice on BioSpace Insmed Incorporated announced that it has commenced an underwritten public offering of up to $250 million of its common stock. Insmed Announces Proposed Public Offering of Common Stock May 20, 2019 /PRNewswire/ -- Insmed Incorporated ( INSM ) announced today that it has commenced an underwritten public offering of up to $250 million of its common stock. * Insmed announces proposed public offering of common stock * Insmed Inc - Has commenced an underwritten public offering of $250 million of shares of its common stock * Insmed - Intends to use net proceeds from offering to fund ongoing and future clinical development All of the shares in the offering will be sold by Insmed. Insmed Incorporated announced today that it is offering $60 million of its common stock in a proposed underwritten public offering. BRIDGEWATER, N.J., Mar 30, 2015 (BUSINESS WIRE) -- Insmed Incorporated INSM, +4.82% announced today that it has commenced an underwritten public offering of 10.0 million shares of its common stock
BRIDGEWATER, N.J., May 20, 2019 /PRNewswire/ -- Insmed Incorporated (Nasdaq: INSM) announced today that it has commenced an underwritten public offering of up to $250 million of its common stock. In addition, Insmed intends to grant the underwriters a 30-day option to purchase up to an additional $25.5 million of its common stock at the public offering price, less the underwriting discounts and commissions. BRIDGEWATER, N.J., May 20, 2019 /PRNewswire/ -- Insmed Incorporated (INSM) announced today that it has commenced an underwritten public offering of up to $250 million of its common stock. In BRIDGEWATER, N.J., May 20, 2019 /PRNewswire/ -- Insmed Incorporated (Nasdaq: INSM) announced today that it has commenced an underwritten public offering of up to $250 million of its common stock. In addition, Insmed intends to grant the underwriters a 30-day option to purchase up BRIDGEWATER, N.J., Sept. 05, 2017 (GLOBE NEWSWIRE) -- Insmed Incorporated (Nasdaq:INSM) announced today that it has commenced an underwritten public offering of $250 million of shares of its common stock. All of the shares of common stock in the offering would be sold by Insmed. In addition, Insmed intends to grant the underwriters a 30-day option to purchase up to an additional 15 percent of the shares of common stock offered in the public offering at the public offering price, less the Insmed Incorporated INSM, +4.10% announced today that it has commenced an underwritten public offering of $250 million of shares of its common stock. All of the shares of common stock in the offering would be sold by Insmed.